Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
- Previous Close
3.9800 - Open
3.9800 - Bid 4.0100 x --
- Ask 4.0200 x --
- Day's Range
3.9600 - 4.0400 - 52 Week Range
3.7700 - 6.3500 - Volume
10,820,800 - Avg. Volume
13,336,673 - Market Cap (intraday)
3.176B - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 8, 2021
- 1y Target Est
--
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.
www.gzcci.com5,509
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 600594.SS
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600594.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600594.SS
Valuation Measures
Market Cap
3.15B
Enterprise Value
3.37B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.16
Price/Book (mrq)
1.05
Enterprise Value/Revenue
1.24
Enterprise Value/EBITDA
82.88
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.33%
Return on Assets (ttm)
0.62%
Return on Equity (ttm)
-0.68%
Revenue (ttm)
2.71B
Net Income Avi to Common (ttm)
-9.06M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
770.6M
Total Debt/Equity (mrq)
23.09%
Levered Free Cash Flow (ttm)
530.17M
Research Analysis: 600594.SS
Company Insights: 600594.SS
600594.SS does not have Company Insights